I'd rather they take their time and get it right. Who cars if it's a month later?
Takes the pressure off all involved (recruiting for the study, getting the protocols spot on etc etc) and it will be nice to beat the more relaxed time frame.
Solid platform for a big rerate next year in my opinion.
RAP Price at posting:
7.7¢ Sentiment: Buy Disclosure: Held